GENE ONLINE|News &
Opinion
Blog

mRNA-1273
COVID-19: Moderna Enters Manufacturing Agreement with Samsung Biologics after Vaccine Bags Conditional Nod in South Korea
2021-05-23
Top Announcements from the J.P. Morgan Healthcare Conference 2021
2021-01-13
Pick your Potion, An Overview of the COVID Vaccines
2020-12-31
Moderna’s COVID-19 Vaccine Bags FDA’s Emergency Use Authorization, Inoculations to Start on Monday
2020-12-19
FDA Panel Recommends Moderna’s COVID-19 Vaccine for Emergency Use Authorization
2020-12-17
Final Analysis Suggests Pfizer, BioNTech’s COVID-19 Vaccine is Safe with 95% Efficacy
2020-11-18
How Does Moderna’s mRNA Vaccine Measure Up to Pfizer’s?
2020-11-16
Moderna’s Shares Surge Following Claims of 94.5% Efficacy for its COVID-19 Vaccine
2020-11-16
Takeda Plans to Distribute 50 Million Doses of Moderna’s COVID-19 Vaccine in Japan
2020-11-01
COVID-19 Vaccine: Moderna Begins Phase 3 COVE Study of mRNA-1273
2020-07-27
COVID-19: Moderna Registers Positive Phase 1 Results for mRNA Vaccine
2020-05-18
LATEST
2024 Nobel Prize in Medicine: Uncovering the Secrets of microRNA in Gene Regulation
2024-10-08
Sciwind Biosciences Announces Oral Presentation on Oral GLP-2 Research Progress at the 32nd United European Gastroenterology Week (UEG Week 2024)
2024-10-07
Bio Japan 2024 and Medical Japan 2024 Unleashing Innovation in Biopharmaceuticals and Healthcare Technologies
2024-10-07
Starboard Value Takes $1 Billion Stake in Pfizer, Eyes Major Overhaul
2024-10-07
Generative AI Makes its Debut in Smart Healthcare with NVIDIA Experts at the Helm
2024-10-04
How TCELS is Moving Thailand’s Biotech Industries From Local to Global
2024-10-04
Lilly Invests $4.5B in Indiana Facility for In-House Clinical Manufacturing
2024-10-03
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
2024-10-28
BioFuture 2024
New York, U.S.A.
2024-10-30
AusBiotech 2024
Melbourne, Australia
2024-11-04
BIO-Europe 2024
Stockholm, Sweden
Scroll to Top